Credit Suisse 31st Annual Healthcare Conference
Rosa Tye presents on the topic of “The Implications of the Inflation Reduction Act for Drug Market Access.” For more information on this event, click here.
Rosa Tye is a principal in CRA’s Life Sciences Practice, based in San Francisco. She is a life sciences and healthcare strategy consultant with more than eight years of experience advising pharmaceutical and biotech clients across a range of functions, including commercial, market access, medical affairs, and public affairs.
Rosa consults on a mix of global commercial strategy and market access issues across a broad range of therapeutic areas, with a focus in oncology, rare disease, and endocrinology.